ICML 2019 | MANTLE-FIRST results: outcomes in R/R younger MCL by therapy type

Umberto Vitolo

The results from the MANTLE-FIRST study are discussed here by Umberto Vitolo, MD, Città della Salute e della Scienza University Hospital, Turin, Italy, at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland. The outcomes of younger patients with relapsed/refractory mantle cell lymphoma (MCL) are explored.

Share this video  
Similar topics